Picture of Elixinol Wellness logo

EXL Elixinol Wellness Income Statement

0.000.00%
au flag iconLast trade - 00:00
Consumer CyclicalsHighly SpeculativeMicro CapNeutral

Annual income statement for Elixinol Wellness, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.

R2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue31.315.19.387.088.48
Cost of Revenue
Gross Profit16.96.774.943.263.63
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses11811426.818.116.4
Operating Profit-86.3-99-17.4-11-7.92
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-88-100-17.1-10.6-7.5
Provision for Income Taxes
Net Income After Taxes-80.5-104-17-10.6-7.51
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-82.9-105-17-10.6-7.51
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-82.9-105-17-10.6-7.51
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.168-0.177-0.037-0.024-0.01